Cohance Lifesciences schedules investor roadshow in Hyderabad

Cohance Lifesciences Limited has announced an upcoming analyst and institutional investor roadshow scheduled for December 17, 2025. The company will participate in the B&K Hyderabad Day, a group meeting held in Hyderabad. This disclosure aligns with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The announcement emphasizes that no unpublished price-sensitive information will be shared during this interaction. Cohance Lifesciences noted that the meeting schedule is subject to change due to exigencies on the part of the analyst, institutional investor, or the company.

Kundan Kumar Jha, company secretary, compliance officer, and head-legal, signed the intimation on December 13, 2025. The company's corporate office is located in Hyderabad, Telangana, India.